As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is needed for industry-wide adoption.

SK bioscience announced that, together with IDT Biologika (IDT) and Australian biotechnology company Vaxxas, it has been ...

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...

BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...

A recent study on DNA microarray technology highlights its essential role in enabling high-throughput analysis of large numbers of genes through arrays of probes integrated on a solid-phase support.

Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technology Research builds on Emory’s ...

The market for microarray analysis has reached a mature phase and is on a strong growth path, driven by increasing demand for precision medicine and progress in genetic and genomic studies. It ...